Systemic administration of beta‐blockers vs placebo or no treatment
Progression to stage 3 ROP · Prevention of retinopathy of prematurity in preterm infants
Systemic administration of beta‐blockers probably leads to lower progression to stage 3 ROP compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
- Beta‐blockers for prevention and treatment of retinopathy of prematurity in preterm infants 2018 · Cochrane Headline outcomes onlyRR 0.6 [0.37, 0.96]2 studies · 161 participantsModerate